FDA Investigator Gary J Hagan

Gary J Hagan has conducted inspections on 80 sites in 1 countries as of 27 Jul 2009. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
80
Last Inspection Date:
27 Jul 2009
Investigator Role:
FDA Investigator
Redica ID:
100002680
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Gary J Hagan:
Abby E Pelletier, Alice C Silva, Alois P Provost, Althea A Williams, Amber G Wardwell, Amy C Jordan, Andrew M Barlow, Anthony C Warchut, Anthony P Costello, Anthony W Thomas, Asia D Clark, Bo Chi, PhD, Brenda P King, Bruce R Ota, Byungja E Marciante, Camerson E Moore, Carla C Cummins, Carla C Tuite, Carla E Lavallee, CDR Jeremy L Wally, PhD, Charles A Snipes, PhD, Charles R Bonapace, PhD, Charlotte Hinkle, Chiang Syin, PhD, Christine L Williams, Christopher K Vantwuyver, Christopher M Elliott, Constance Desimone, Courtney N Long, Cynthia Jim, CSO, Cynthia Whitmarsh, Darin S Wiegers, David P Vanhouten, Dell S Moller, Dien N Nguyen, Dolores Harper, Donna J Clevenger, Dr. Abhijit Raha, PhD, Dr. Mark J Seaton, PhD, Dr. Robert C Horan, MD, Dr. Sriram Subramaniam, PhD, Dr. Zhou Chen (nmi), MD PhD, Edmund F Mrak, Jr, Edward J Janik, Elizabeth B Griffin, Elizabeth Ll Edwards, Ellen P Madigan, Erin P Conlin, Frank J Koch, Gam S Zamil, Garry H Stewart, Geoffrey K Kilili, George T Allen, Jr, Gerard D Difiore, James H Tanner, James W Whitney, Jamie S Mathews, Jason A Rossi, Jayaleka J Amarasinghe, John A Hamilton, III, John A Sciacchitano, John L Zaccone, John P Mistler, John S Hartford, Jonah S Ufferfilge, Jonathan B Lewis, Jonathan G Matrisciano, Jose A Torres, Joseph Foley, Joseph H Procopio, Jr, Justin A Boyd, Justine M Corson, Karen Mcnabb Noon, Katherine D Adams, Kathleen E Mcafoose, Kent A Conforti, Kristina J Donohue, Lauren M Lawrance, LCDR Debra Emerson, Leo B Zadecky, Li Yun Huang, Lorayne A Mcguinness, Lori M Newman, Louis Christy, Margaret E Walsh, Margaret M Sands, Mariza M Jafary, Martin J Guardia, Mary Jeanet Mcgarry, Maryam Tabatabaie, Matthew C Watson, Maura Rooney, Maya M Davis, Megan A Haggerty, Michael F Skelly, PhD, Michael P Anthony, Michael P Sweeney, Michelle M Noe Varga, Mihaly S Ligmond, Monique C Lo, Nabil Nakhoul, Nealie C Newberger, Paraluman S Leonin, Paul L Bellamy, Paul P Geraci, Philip Kreiter, Phillip E Mclaughlin, Prabhu P Raju, Ramon E Martinez, Richard A Abate, Richard F Hapke, Richard H Penta, Richard L Licari, Robert D Ogan, Robert J Martin, Robert O'brian, Rory K Geyer, Sandra P White, Sean R Marcsisin, Seth A Mailhot, Sharon K Thoma, PharmD, Sherry M Nisson, Shirley S Wen, Simone E Pitts, Slater K Bartlett, Stacey S Degarmo, Stephen C Smith, Steve Papagiotas, Susanne M Richardson, MS RAC, Suzanne M Healy, Tamara S Rosbury, Teddy Tom, Thomas J Arista, Thomas W Nerney, Troy R Petrillo, Victor J Gangi, Victoria Taylor, Wendy A Johnecheck, Weston K Szymanski, Xiaokuang Lai, PhD, Ze Peng, Zhongren Wu

Gary J Hagan's Documents

Publish Date Document Type Title
December, 2002 FDA 483 Response New England Institutional Review Board - Form 483R, 2003-01-27
June, 2000 EIR H. David Mitcheson, MD - EIR, 2000-06-01
April, 2002 FDA 483 Biogen, Inc. - Form 483, 2002-04-12
September, 2003 FDA 483 Response Gwathmey, Inc. - Form 483R, 2003-10-16
August, 2009 FDA 483 Millennium Pharmaceuticals, Inc. - Form 483, 2009-08-05
September, 2003 FDA 483 Gwathmey, Inc. - Form 483, 2003-09-25
June, 2001 FDA 483 Labcorp Bedford LLC. - Form 483, 2001-06-08
February, 2001 FDA 483 Massachusetts General Hospital - Form 483, 2001-02-14
January, 2000 FDA 483 Cytosol Laboratories, Inc. - Form 483, 2000-01-18
March, 2001 FDA 483 Laurence Katznelson, M.D. - Form 483, 2001-03-26
June, 2001 EIR Labcorp Bedford LLC. - EIR, 2001-06-08
July, 2003 EIR Reliant Medical Group IRB - EIR, 2003-07-02
April, 2000 FDA 483 Charles River Laboratories Preclinical Services - Form 483, 2000-04-12
August, 2002 FDA 483 The New England College of Optometry - Form 483, 2002-08-06
September, 2003 EIR Gwathmey, Inc. - EIR, 2003-09-25
February, 2003 EIR First Boston Pharma LLC - EIR, 2003-02-05
June, 2005 FDA 483 Charles River Laboratories, Inc. - Form 483, 2005-06-15
March, 2000 EIR Massachusettes Eye and Ear Infirmary Inc. - EIR, 2000-03-03
July, 2003 FDA 483 Reliant Medical Group IRB - Form 483, 2003-07-02
February, 2003 FDA 483 First Boston Pharma LLC - Form 483, 2003-02-05
May, 2003 EIR Massachusetts General Hospital - EIR, 2003-05-01
April, 2000 FDA 483 Response Charles River Laboratories Preclinical Services - Form 483R, 2000-04-17
March, 2000 FDA 483 Massachusettes Eye and Ear Infirmary Inc. - Form 483, 2000-03-03
April, 2000 EIR Charles River Laboratories Preclinical Services - EIR, 2000-04-12
July, 2001 EIR Charles River Laboratories Preclinical Services - EIR, 2001-07-30
August, 2003 FDA 483 Charles River Laboratories, Inc. - Form 483, 2003-08-12
December, 2002 EIR New England Institutional Review Board - EIR, 2002-12-19
July, 2001 FDA 483 Charles River Laboratories Preclinical Services - Form 483, 2001-07-30

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more